
The regulator of the state medical insurance coverage fund mentioned authorities ordered the arrest of all suspects, however didn’t give particulars of the suspected violations or the dimensions of funds concerned.
It demanded that AstraZeneca China shut loopholes in supervision of selling actions, the NHSA added.
In an announcement on Friday, the corporate mentioned some staff within the southern metropolis of Shenzhen had altered or participated in altering sufferers’ testing studies, and have been suspected of medical insurance coverage fraud.
The NHSA and public safety ministry held a gathering with firm officers in December to transient them on the investigation, it added.
“AstraZeneca China takes such worker misconduct significantly and welcomes the suggestions by the NHSA and MOPS,” it mentioned.
An AstraZeneca spokesperson mentioned all staff concerned within the Shenzhen case have been Chinese language nationals.
The corporate has taken disciplinary motion towards these staff and has reported their violations to the authorities, the assertion mentioned.
Authorities will launch nationwide campaigns to stamp out fraud that includes altering genetic check outcomes, the NHSA added, urging these answerable for such violations to show themselves in.